Current approaches to prevention and treatment of antiphospholipid syndrome
- Authors: Nasonov EL1
-
Affiliations:
- Issue: Vol 78, No 5 (2003)
- Pages: 83-87
- Section: Editorial
- Submitted: 09.04.2020
- Published: 15.05.2003
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29407
- ID: 29407
Cite item
Full Text
Abstract
Keywords
References
- Hughes G. R. V. The antiphospholipid syndrome: ten years on. Lancet 1993; 324:341-344.
- Насонов Е. Л., Алекберова З. С., Калашникова Л. А. и др. Антифосфолипидный синдром (синдром Hughes): 10 лет изучения в России. Клин. мед. 1998; 2: 4-11.
- Asherson R., Cervera R., Pietle J.-С., Shoenfeld Y., eds. The antiphospholipid syndrome. Boca Raton: CRC Press, 1996.
- Насонов E. Л., Баранов А. А., Шилкина Н. П., Алекберова 3. С. Патология сосудов при антифосфолипидном синдроме. М.; Ярославль; 1995.
- Levine J. S., Branch D. W., Ranch J. The antiphospholipid syndrome. N. Engl. J. Med. 2000; 346: 752-763.
- Erkan D., Yazici Y., Peterson M. G. et al. A cross-sectional study of clinical thrombotic risk factors and preventive treatment in antiphospholipid syndrome. Rheumatology 2002; 41: 924-929.
- Brimner H. I., Chan W.-E., Ginsberg J. S., Feldman В. М. Long term anticoagulation is preferable for patients with antiphospholipid antibody syndrome: result of a decision analysis. J. Rheumatol. 2002; 29: 490-501.
- Wilson W. A., Charavi A. E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr. and Rheum. 1999; 42:1309-1311.
- Goodnight S. Anticoagulation therapy for the antiphospholipid syndrome. In: Asherson R. A., Cervera R.. eds. Vascular manifestations of systemic autoimmune diseases. Boca Raton: CRC Press; 2000. 563-570.
- Derksen R. H. M., de Groot Ph. G., Nieuwenhuis H. К. М, Christiaens G. С. М. L. How to treat women with antiphospholipid antibodies in pregnancy. Ann. Rheum. Dis. 2001; 60: 1-3.
- Насонов Е. Л., Иванова М. М. Антималярийные (аминохинолиновые) препараты: новые фармакологические свойства и перспективы клинического применения. Клин. фармакол. и тер. 1998; 3: 65-68.
- Weitz J. I. Low molecular weight heparins. N. Engl. J. Med. 1997; 337: 688-698.
- Lockwood С. J., Schur P. H. Monitoring and treatment of pregnant women with the antiphospholipid antibody syndrome. UpToDate 2002; 10(2).